Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Study for Performance of Septin 9 in Plasma From Cases With Colorectal Cancer and Controls With Non-Diseased, Non-Colorectal Disease and Non-Colorectal Cancers

NCT00696345 is registered in ClinicalTrials.gov with Epigenomics, Inc as lead sponsor.

NCT NCT00696345
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00696345 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Study for Performance of Septin 9 in Plasma From Cases With Colorectal Cancer and Controls With Non-Diseased, Non-Colorectal Disease and Non-Colorectal Cancers
Lead sponsor
Epigenomics, Inc
Phase
Observational
Overall status
Completed
Start date
January 31, 2005
Completion date
February 28, 2007
Enrollment
700 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer